---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-066051"
form_type: "8-K"
ticker: "ORIC"
cik: "0001796280"
company_name: "Oric Pharmaceuticals, Inc."
filed_at: "2022-03-04T23:59:59+00:00"
generated_at: "2026-06-27T01:40:29.360865+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# ORIC Pharmaceuticals adopts 2022 Inducement Equity Incentive Plan reserving 500,000 shares

## Summary
- Plan adopted March 1, 2022 by Compensation Committee; 500,000 shares of common stock reserved.
- Awards limited to new employees as material inducement to hire, per Nasdaq Listing Rule 5635(c)(4).
- Terms substantially similar to company's 2020 Equity Incentive Plan.
- Adopted without stockholder approval; approved by independent directors.

## SEC filing metadata
- accession: 0001193125-22-066051
- form_type: 8-K
- ticker: ORIC
- cik: 0001796280
- company_name: Oric Pharmaceuticals, Inc.
- filed_at: 2022-03-04T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1796280/000119312522066051/0001193125-22-066051-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1796280/000119312522066051/d253295d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-066051
- JSON: https://secwatch.observer/filing/0001193125-22-066051.json
- Plain text: https://secwatch.observer/filing/0001193125-22-066051.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.